Nice spot.... Tech is a confusing minefield right now. Chip shortage is very bad still & virus still reeking havoc with certain Far east factories.
I'm looking at SMOD today.
testing its
10-week moving averageon a pullback.<---------
Silicon Motion reports its fourth-quarter
results on Thursday morning, with an estimated EPS of $1.76 and revenue of $262 million. The company will hope to end the fiscal year off in style: 2021 full-year earnings per share estimated at $6.01, over an 85% increase from a year prior. Analysts expect growth to continue into next year, with 2022 EPS projected at $7.11.
AND VERTEX<----- I think you are already in. I recommended this name to you once before.
Vertex Reports Wednesday after close.
Vertex Pharmaceuticals(
VRTX) is another drug manufacturer displaying impressive profit growth. The maker of cystic fibrosis drugs is set to report earnings on Wednesday after the market close.
EPS is estimated at $3.26, with a revenue of $2 billion. Investors should expect beats on both these numbers, as with AmerisourceBergen. Vertex analysts have consistently underestimated numbers. The company has beat both EPS and revenue estimates for 12 straight quarters.
Vertex Pharmaceuticals has had an impressive growth rate, with three-year EPS and sales growth rates at 56% and 29%, respectively. Vertex is forming a long base with a handle and has a 224.50 buy point,
TODAY IDEAS))))))
SMOD-$ 83.50
VRTX- $227